Study of ANX007 in Participants With Primary Open-angle Glaucoma
Condition: Open Angle Glaucoma Interventions: Biological: 2.5mg ANX007; Biological: 5.0mg ANX007; Other: Sham Procedure Sponsor: Annexon, Inc. Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials